Axsome Therapeutics, Inc. (AXSM) Analyst Estimates Annual - Discounting Cash Flows
AXSM
Axsome Therapeutics, Inc.
AXSM (NASDAQ)
Period Ending: 2030
12-31
2029
12-31
2028
12-31
2027
12-31
2026
12-31
2025
12-31
2024
12-31
2023
12-31
2022
12-30
Number of Analysts 13 9 14 17 15 16 11 9 3
Estimated Revenue
Low 2,834 2,396 2,094 1,202 896.4 624.9 380.4 253.5 42.96
Average 3,259 2,755 2,099 1,517 984.9 635.7 385.1 291.5 46.98
High 3,679 3,110 2,103 1,798 1,103 638.9 387.8 329 50.74
Estimated EBITDA
Low -1,324 -1,119 -756.9 -647.1 -397 -229.9 -139.6 -118.4 -5.46
Average -1,173 -991.6 -755.3 -545.8 -354.4 -228.8 -138.6 -104.9 -5.06
High -1,020 -862.3 -753.6 -432.4 -322.6 -224.9 -136.9 -91.22 -4.63
Estimated EBIT
Low -1,358 -1,148 -776.2 -663.6 -407.1 -235.8 -143.1 -121.4 -5.93
Average -1,203 -1,017 -774.5 -559.7 -363.5 -234.6 -142.1 -107.6 -5.49
High -1,046 -884.2 -772.8 -443.5 -330.8 -230.6 -140.4 -93.55 -5.02
Estimated Net Income
Low 1,074 857.1 325.4 5.02 -268.6 -210.6 -318.7 -378.3 -229.2
Average 1,293 1,032 757.7 402.4 26.59 -183.7 -246.9 -308.6 -207.6
High 1,509 1,205 1,158 671.2 249.4 -169.7 -240 -269.1 -184.5
Estimated SGA Expenses
Low 4,159 3,516 3,073 1,763 1,315 917 558.3 371.9 63.96
Average 4,783 4,043 3,080 2,225 1,445 932.8 565 427.7 69.94
High 5,399 4,564 3,086 2,638 1,619 937.6 569.1 482.8 75.54
Estimated EPS
Low 21.58 17.23 6.54 0.101 -5.4 -4.23 -6.41 -7.61 -4.78
Average 25.99 20.75 13.69 5.97 -0.428 -3.76 -5.46 -6.51 -4.33
High 30.34 24.22 23.29 13.49 5.01 -3.41 -4.83 -5.41 -3.85
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program